首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1624397

蛋白質體學市場規模：按儀器技術、按試劑、按軟體和服務、按應用、按最終用戶、按地區、範圍和預測

Proteomics Market Size By Instrumentation Technologies, By Reagent, By Software & Services (Core Proteomics Services, Bioinformatics Software & Services, By Application, By End-User, By Geographic Scope And Forecast

出版日期: 2024年10月14日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

蛋白質體學市場規模及預測

2023年蛋白質體學市場規模為326.5億美元，預計2024年至2031年複合年增長率為14.62%，2031年達到972.3億美元。蛋白質體學是對細胞、組織和生物體等生物樣本中發現的所有蛋白質的研究。蛋白質體學識別、表徵和量化蛋白質，並研究它們在生物系統內的相互作用、變化和活動。蛋白質體學包括多種技術和方法，包括質譜、凝膠電泳、蛋白質微陣列和生物資訊工具。蛋白質體學有廣泛的應用，包括生物醫學研究、藥物開發、個人化治療和農業。

此外，蛋白質體學透過提高作物產量、品質和對環境課題的抵抗力來推進農業研究。

全球蛋白質體學市場動態

主要市場推動因素

慢性病盛行率增加：

癌症、糖尿病和心血管疾病等慢性病的盛行率不斷上升，推動了對蛋白質體學研究的需求。這項研究對於瞭解疾病病理學、促進標靶藥物和個人化醫療的發展以及推動市場需求至關重要。

擴大研發投入：

政府和公司正在增加蛋白質體研究的資金分配。這筆資金將支持蛋白質體學研究，在疾病診斷、藥物發現和治療監測方面取得重大進展，並推動市場進步。

技術進步：

質譜和生物資訊學的進步極大地簡化了蛋白質體學研究。這些發展使蛋白質分析更加準確、靈敏和更快，增加了我們對細胞過程和疾病機制的瞭解，並推動了市場發展。

製藥和生物技術產業的擴張：

製藥和生技產業正在迅速擴張，特別注重新藥發現和精準醫療。蛋白質體學對這些行業至關重要，因為它可以識別新的藥物標靶和生物標記物，簡化藥物開發過程，並提高藥物功效和安全性。

主要課題

蛋白質體學研究的高成本：

先進的蛋白質體學技術，例如質譜和高通量測序，需要在設備和維護方面進行大量投資。高成本限制了小型研究機構的使用並阻礙了廣泛採用。

蛋白質體複雜性：

人類蛋白質體極為複雜，許多蛋白質都會發生翻譯後變化。這種複雜性使得準確識別和量化蛋白質變得困難，需要昂貴的分析技術和計算工具，並限制了市場擴張。

有限生物標記的驗證：

儘管透過蛋白質體學研究發現了多種生物標記的潛力，但臨床使用的驗證過程漫長而困難。因此，需要大規模研究來證明臨床有效性，而嚴格的驗證要求阻礙了蛋白質體學發現轉化為診斷和治療。

主要趨勢：

質譜技術的進步：

質譜技術的不斷進步，包括靈敏度、解析度和通量的提高，使得蛋白質體學研究能夠進行更詳細的研究。這一趨勢將使人們能夠對蛋白質組進行更詳細的研究，包括翻譯後變化和蛋白質-蛋白質相互作用。

個人化醫療的成長：

蛋白質體學在個人化醫療中的應用越來越廣泛，重點是發現用於疾病診斷、預後和藥物選擇的生物標記。這一趨勢正在加速基於個別蛋白質體譜的標靶藥物和個人化醫療策略的發展。

協作研究與多組學方法：

人們越來越重視協同研究和多組學技術的使用，包括蛋白質組學、基因組學、轉錄組學和代謝組學。這種生物系統的整體觀點可以讓我們更全面地瞭解疾病機制並確定新的治療標靶。

Proteomics Market size was valued at USD 32.65 Billion in 2023 and is projected to reach USD 97.23 Billion by 2031, growing at a CAGR of 14.62% from 2024 to 2031. Proteomics is the study of all proteins found in a biological sample, such as cells, tissues, or organisms. It entails identifying, characterizing, and quantifying proteins, as well as investigating their interactions, changes, and activities within biological systems. Proteomics includes a diverse set of techniques and approaches, such as mass spectrometry, gel electrophoresis, protein microarrays, and bioinformatics tools. Proteomics has a wide range of applications, including biomedical research, drug development, personalized treatment, and agriculture.

Furthermore, proteomics promotes agricultural research by increasing crop output, quality, and tolerance to environmental challenges.

Global Proteomics Market Dynamics

The key market dynamics that are shaping the Proteomics Market include:

Key Market Drivers

Increasing Prevalence of Chronic Diseases:

The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease is propelling the demand for proteome research. This research is critical in understanding disease pathology, which will lead to the development of targeted medicines and personalized medicine, and propel market demand.

Growing Investment in Research and Development:

The government and corporate sectors are increasing their allocation of cash for proteome research. This financing supports proteome research, which will lead to substantial advances in disease diagnostics, drug discovery, and treatment monitoring and fosters the market to move forward.

Technological Advancements:

Mass spectrometry and bioinformatics advances have made proteomics research substantially more effective. These developments make protein analysis more precise, sensitive, and faster, allowing for a better knowledge of cellular processes and disease mechanisms, and driving market expansion.

Expansion of Pharmaceutical and Biotechnology Industries:

The pharmaceutical and biotechnology industries are quickly increasing, with a significant emphasis on new drug discovery and precision medicine. Proteomics is crucial in these industries because it identifies novel drug targets and biomarkers, streamlines the drug development process and improves drug efficacy and safety.

Key Challenges:

High Cost of Proteomics Research:

Advanced proteomics technologies, such as mass spectrometry and high-throughput sequencing, need a large investment in equipment and maintenance. The hefty prices limit access for smaller research institutes and prevent widespread adoption.

Complexity of the Proteome:

The human proteome is extremely complicated, with a large number of proteins that undergo post-translational changes. This complexity makes it difficult to precisely identify and quantify proteins, necessitating expensive analytical techniques and computational tools, and restricting market expansion.

Limited Biomarker Validation:

Despite the discovery of multiple possible biomarkers through proteomic research, the validation process for clinical usage is lengthy and difficult. Thus, severe validation requirements, combined with the necessity for large-scale investigations to prove clinical relevance, hinder the translation of proteomic discoveries into diagnostics and therapies.

Key Trends:

Advancements in Mass Spectrometry Technology:

Mass spectrometry's continuous advances, including improved sensitivity, resolution, and throughput, allow for more thorough proteome investigations. This trend enables a more in-depth investigation of the proteome, including post-translational changes and protein-protein interactions.

Growth in Personalized Medicine:

Proteomics is becoming more widely used in personalized medicine, with an emphasis on discovering biomarkers for illness diagnosis, prognosis, and medication selection. This trend is accelerating the development of targeted medicines and personalized healthcare strategies based on individual proteome profiles.

Collaborative Research and Multi-Omics Approaches:

There is an increasing emphasis on collaborative research and the use of multi-omics techniques that include proteomics, genomics, transcriptomics, and metabolomics. This holistic view of biological systems allows for a more complete knowledge of disease mechanisms and the identification of new treatment targets.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Proteomics Market Regional Analysis

Here is a more detailed regional analysis of the Proteomics Market:

North America:

According to Verified Market Research, North America is estimated to dominate the market over the forecast period. North America, particularly the United States, has a sophisticated research infrastructure, with world-class research institutes and laboratories. This allows for cutting-edge proteomics research and technical innovation, resulting in the region's dominance in the Proteomics Market.

The region has received significant government and private sector funding in biotechnology and pharmaceutical research, including proteomics. This financing supports a diverse spectrum of proteomics initiatives, from basic research to therapeutic applications, hence promoting market growth.

Chronic diseases such as cancer, cardiovascular disease, and diabetes are prevalent in North America. The critical need for improved diagnostics and therapeutics for various diseases is fueling demand for proteome research and applications in drug development and personalized medicine.

Furthermore, many of the world's top biopharmaceutical companies are based in North America. These firms are actively engaged in proteomics research for medication discovery and development, contributing significantly to the region's dominant position in the worldwide Proteomics Market.

Europe:

Europe benefits from strong cross-national and institutional collaboration, which is encouraged by EU funding projects such as Horizon Europe. These collaborations and funding opportunities promote widespread proteome research, hence stimulating innovation and growth in the European Proteomics Market.

European healthcare systems are progressively implementing precision medicine approaches that rely on proteomics for biomarker identification and illness understanding. This shift towards personalized therapies is driving demand for proteomic technology and services.

Europe's strong healthcare infrastructure, which includes well-equipped laboratories and research facilities, serves as a solid platform for proteomics research and clinical applications. This infrastructure enables the development and implementation of proteomic technologies across the continent.

Furthermore, Europe bears a high load of chronic diseases, necessitating improved diagnostic and therapeutic approaches. Proteomics is critical in tackling this challenge, resulting in increased investment and interest in the discipline throughout the region.

Asia Pacific:

Asia Pacific is estimated to exhibit the highest growth during the forecast period. The region is undergoing significant economic growth, resulting in greater investment in healthcare infrastructure and research. This investment is accelerating the implementation of new technologies, such as proteomics, to improve healthcare outcomes.

Asia Pacific countries, particularly China and India, are experiencing considerable growth in their pharmaceutical and biotechnology sectors. This growth includes expanded R&D activity in proteomics for drug discovery and development, which will boost the region's Proteomics Market.

The region is experiencing an increase in chronic diseases such as cancer, cardiovascular disease, and diabetes. This has increased demand for proteome research to generate better diagnostic tools and therapeutics, driving market growth.

Furthermore, governments in the Asia Pacific are enacting legislation and providing financial assistance to encourage innovation in biotechnology and life sciences, including proteomics. Such activities are critical for developing research capacity and attracting investment, hence allowing the Proteomics Market's rapid expansion.

Global Proteomics Market: Segmentation Analysis

The Global Proteomics Market is segmented on the basis of Instrument Technologies, Reagent, Software & Service, Application, End-User, And Geography.

Proteomics Market, By Instrumentation Technologies

Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-ray Crystallography
Surface Plasmon Resonance
Protein Fractionation
Others

Based on Instrumentation Technologies, the market is segmented into Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-ray Crystallography, Surface Plasmon Resonance, Protein Fractionation, and Others. The spectroscopy segment is estimated to exhibit the highest growth within the Proteomics Market due to spectroscopy, particularly mass spectrometry (MS), which is critical for protein identification, quantification, and analysis. Mass spectrometry, a fundamental technique in the spectroscopy category, offers unrivaled sensitivity, precision, and depth of analysis for examining complex proteomes, making it essential for proteomics research. Its capacity to analyze a wide range of biomolecules, from small peptides to big proteins and complexes, combined with advances in MS technology, such as enhanced speed, resolution, and throughput, solidifies its position as a cornerstone technique in proteomics.

Proteomics Market, By Reagent

Immunoassay Reagents
Spectroscopy Reagents
Chromatography Reagents
Electrophoresis Reagents
Protein Microarrays Reagents
X-ray Crystallography Reagents
Protein Fractionation Reagents
Others

Based on Reagent, the market is segmented into Immunoassay, Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-ray Crystallography, Protein Fractionation Reagents, and Others. The immunoassay reagent segment is estimated to dominate the Proteomics Market due to the extensive use of immunoassays for protein identification and quantification in a variety of applications, ranging from basic research to clinical diagnosis. Immunoassay reagents are essential for many proteomic research because of their specificity, sensitivity, and adaptability in detecting and quantifying proteins and their changes. They are used in a variety of platforms, including ELISA, western blotting, and multiplex assays, to help analyze protein expression, function, and relationships.

Proteomics Market, By Software & Service

Core Proteomics Services
Bioinformatics Software & Services

Based on Software & Services, the market is segmented into Core Proteomics Services and Bioinformatics Software & Services. The bioinformatics software & service segment is estimated to dominate the global market due to bioinformatics' crucial role in managing, analyzing, and interpreting the massive volumes of data produced by proteomic investigations. As proteomics technology, particularly mass spectrometry, advances, the number and complexity of data grow tremendously. Bioinformatics software and services are critical tools for data analysis, visualization, and integration, allowing researchers to decode complex biological data and identify new proteins, biomarkers, and therapeutic targets.

Proteomics Market, By Application

Clinical Diagnostics
Drug Discovery & Development
Others

Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, and Others. The drug discovery & development application is estimated to hold the majority share in the forecast period of the Proteomics Market due to proteomics' crucial position in the pharmaceutical and biotechnology industries, where it is widely utilized to find and validate new drug targets, study pharmacological mechanisms of action, and track therapeutic responses. The capacity of proteomics to provide complete insights into the molecular underpinnings of diseases as well as the impact of medications on the proteome makes it an invaluable tool in the drug discovery process.

Proteomics Market, By End-User

Hospitals
Clinical Laboratories
Pharmaceutical & Biotechnology Companies
Academic Research Laboratories
Others

Based on End-User, the market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Laboratories, and Others. The pharmaceutical & biotechnology companies segment is estimated to show the highest growth in the forecasted period due to these corporations' significant investments in research and development activities such as drug discovery and development, as well as the need for precision medicine. Proteomics tools, such as mass spectrometry and protein microarrays, are critical for understanding disease causes, discovering biomarkers for diagnosis and prognosis, and creating tailored treatments.

Key Players

The "Global Proteomics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Agilent Technologies, Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific, Shimadzu Corporation, Abcam, Bio-Rad Laboratories, Charles River Laboratories, Merck KGaA, Myriad Genetics, Novogen, PerkinElmer, Proteomedix, SomaLogic, TA Instruments, and Bio-Techne.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Proteomics Market Recent Developments
In February 2024, Bruker Corporation announced the launch of its new timsTOF Pro 2 mass spectrometer, which is specifically suited for advanced proteomics research. This equipment has increased sensitivity and speed, promising more detailed insights into complicated protein samples.
In February 2024, Agilent Technologies and Bio-Rad Laboratories announced a collaboration to create and commercialize integrated workflow solutions for proteomics research. This collaboration seeks to streamline operations and improve data quality for researchers.
In February 2024, Thermo Fisher Scientific expanded its clinical proteomics services by introducing new tailored mass spectrometry tests for Alzheimer's disease and other neurodegenerative disorders. This development demonstrates the rising use of proteomics in clinical diagnostics.
In February 2024, SomaLogic, a proteomics service provider known for its SomaScan platform, announced a partnership with AstraZeneca to use its technology for drug discovery and development. This partnership demonstrates the rising use of proteomics in the pharmaceutical business.

1 INTRODUCTION OF GLOBAL PROTEOMICS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PROTEOMICS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL PROTEOMICS MARKET, BY REAGENT

5.1 Overview
5.2 Immunoassay Reagents
5.3 Spectroscopy Reagents
5.4 Chromatography Reagents
5.5 Electrophoresis Reagents
5.6 Protein Microarrays Reagents
5.7 X-ray Crystallography Reagents
5.8 Protein Fractionation Reagents
5.9 Others

6 GLOBAL PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY

6.1 Overview
6.2 Spectroscopy
6.3 Chromatography
6.4 Electrophoresis
6.5 Protein Microarrays
6.6 X-ray Crystallography
6.7 Surface Plasmon Resonance
6.8 Protein Fractionation
6.9 Others

7 GLOBAL PROTEOMICS MARKET, BY SOFTWARE AND SERVICE

7.1 Overview
7.2 Core Proteomics Services
7.3 Bioinformatics Software & Services

8 GLOBAL PROTEOMICS MARKET, BY APPLICATION

8.1 Overview
8.2 Clinical Diagnostics
8.3 Drug Discovery & Development
8.4 Others

9 GLOBAL PROTEOMICS MARKET, BY END-USER

9.1 Overview
9.2 Hospitals
9.3 Clinical Laboratories
9.4 Pharmaceutical & Biotechnology Companies
9.5 Academic Research Laboratories
9.6 Others

10 GLOBAL PROTEOMICS MARKET, BY GEOGRAPHY

10.1 Overview
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 U.K.
- 10.3.3 France
- 10.3.4 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Rest of Asia Pacific
10.5 Rest of the World
- 10.5.1 Latin America
- 10.5.2 Middle East and Africa

11 GLOBAL PROTEOMICS MARKET COMPETITIVE LANDSCAPE

11.1 Overview
11.2 Company Market Ranking
11.3 Key Development Strategies

12 COMPANY PROFILES

12.1 Agilent Technologies
- 12.1.1 Overview
- 12.1.2 Financial Performance
- 12.1.3 Product Outlook
- 12.1.4 Key Developments
12.2 Bruker Corporation
- 12.2.1 Overview
- 12.2.2 Financial Performance
- 12.2.3 Product Outlook
- 12.2.4 Key Developments
12.3 Danaher Corporation
- 12.3.1 Overview
- 12.3.2 Financial Performance
- 12.3.3 Product Outlook
- 12.3.4 Key Developments
12.4 Thermo Fisher Scientific
- 12.4.1 Overview
- 12.4.2 Financial Performance
- 12.4.3 Product Outlook
- 12.4.4 Key Developments
12.5 Bio-Rad Laboratories
- 12.5.1 Overview
- 12.5.2 Financial Performance
- 12.5.3 Product Outlook
- 12.5.4 Key Developments
12.6 Merck KGaA
- 12.6.1 Overview
- 12.6.2 Financial Performance
- 12.6.3 Product Outlook
- 12.6.4 Key Developments
12.7 SomaLogic
- 12.7.1 Overview
- 12.7.2 Financial Performance
- 12.7.3 Product Outlook
- 12.7.4 Key Developments
12.8 Novogen
- 12.8.1 Overview
- 12.8.2 Financial Performance
- 12.8.3 Product Outlook
- 12.8.4 Key Developments
12.9 Myriad Genetics
- 12.9.1 Overview
- 12.9.2 Financial Performance
- 12.9.3 Product Outlook
- 12.9.4 Key Developments
12.10 Abcam
- 12.10.1 Overview
- 12.10.2 Financial Performance
- 12.10.3 Product Outlook
- 12.10.4 Key Developments